Estimate manufacturing timelines.
Global vaccine production capacity reached ~12 billion doses/year by 2022. Manufacturing constraints include raw materials, fill-finish capacity, cold chain logistics, and quality control. mRNA vaccines have faster scale-up than traditional platforms.